Merck has informed that a meeting of the Board of Directors of the Company will be held on February 24, 2017, to consider and approve the audited financial results for the year ended December 31, 2016 and to consider recommendation of dividend for the year 2016.
The above information is a part of company’s filings submitted to BSE.